Novartis Contract ManufacturingNovartis Contract Manufacturing is a global CDMO specialized in biotech, small molecules, cell & gene therapy, and fill & finish. With a quality driven mindset and advanced GMP facilities, we enable our clients to bring their medicines to market reliably, offering tailored manufacturing solutions to meet their unique needs. Over 40 Years of GMP manufacturing experience Over 20 Manufacturing sites globally More than 700 Successful regulatory inspections in last 5 years Achieve Net-Zero Carbon emissions by 2040 Core Services: Mammalian High-tech facilities in Europe and Singapore, fed-batch, intensive fed batch, continuous manufacturing up to 15 kL scale. Microbial end-to-end process and analytical development in Austria with flexible scales up to 40 kL scale. Small Molecules Customized solution from API manufacturing to final product manufacturing in Europe and Asia for all standard dosage forms. Cell and Gene Viral vectors manufacturing in US and Slovenia for vaccines or cell and gene therapy. Proven scale up capabilities, reliable manufacturing processes and unsurpassed industry knowledge. mRNA/LNP | pDNA | siRNA End-to-end supply for nucleic acid therapies from master cell bank manufacturing, plasmid DNA production, peptide synthesis, LNP formulation and drug product. Fill and Finish Aseptic Filling, Assembly & Packaging Aseptic solutions catering to various packaging systems and volumes. Prefilled syringes, vials, cartridges, ointments, dropper bottles, sprays, tubes and more.
